Novo Nordisk acquires Embark Biotech, enters three-year collaboration
Novo Nordisk obtains full rights to develop and commercialise Embark Biotech’s lead programme, in exchange for €15m in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
31 Aug 23
Novo Nordisk obtains full rights to develop and commercialise Embark Biotech’s lead programme, in exchange for €15m in…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
31 Aug 23
The CHMP's opinion was based on the full body of prior clinical, non-clinical, and real-world data supporting the…
31 Aug 23
According to Emergent BioSolutions, the expanded access will give people the ability to respond in an opioid emergency,…
31 Aug 23
The agreement, which excludes geographical Europe, replaces the collaboration and license pact signed between both parties in 2021
31 Aug 23
The entire value chain of medical care, product development and manufacture in focus at one location
31 Aug 23
BEN-8744 is derived from the Benevolent Platform and is a potential first-in-class PDE10 inhibitor for the treatment of…
31 Aug 23
In the U.S., ROCTAVIAN Now Commercially Available and Hemophilia Treatment Centers Have Begun Screening Eligible Individuals
30 Aug 23
Ginkgo will develop large language models (LLMs) for genomics, protein function, and synthetic biology on Google Cloud's Vertex…
30 Aug 23
The partnership will use Immgenuity's IMTV014 and Biostax's Lodonal and JKB-122 to assess if the immune-modulatory effects of…
30 Aug 23
The anti-cancer injection, which takes around seven minutes to administer, has received approval from the Medicines and Healthcare…